In physiciansupervised settings, BPC157 and TB500 have shown favorable safety profiles in preclinical and early clinical use, with most side effects being mild and transient (such as temporary injectionsite irritation or mild digestive changes)
This extends to the performance of our heart, which, after all, must work continuously and therefore requires a constant supply of energy
While your body contains thousands of different peptides that act as signaling molecules, BPC-157 is unique because of its origin story
Common Mistakes to Avoid Over-diluting (weak, unstable solutions)
When to increase dose Consider increasing if: Minimal response after 4-6 weeks at current dose No side effects at current dose Current dose below the higher end of recommended range Goals not being met with conservative approach Increase gradually, typically by 25-50% at a time
Connect with an expert to find out more